p53 Mediates Apoptotic Crisis in Primary Abelson Virus-Transformed Pre-B Cells

REFERENCES

• Attardi, L. D., S. W. Lowe, J. Brugarolas, and J. Jacks 1996. Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J. 15:3693–3701.
   PubMed Web of Science ®Google Scholar
• Baker, S., S. Markowitz, E. Fearson, J. Wilson, and J. Vogelstein 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912–914.
   PubMed Web of Science ®Google Scholar
• Baxter, E. W., K. Blyth, L. A. Donehower, E. R. Cameron, D. E. Onions, and J. Neil 1996. Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: Overlapping pathways in tumor development? J. Virol. 70:2095–2100.
   PubMedGoogle Scholar
• Blyth, K., A. Terry, M. O’Hara, E. W. Baxter, M. Campbell, M. Stewart, L. A. Donehower, D. E. Onions, J. C. Neil, and J. Cameron 1995. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene 10:1717–1723.
   PubMed Web of Science ®Google Scholar
• Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and J. Hannon 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (London) 377:552–556.
   PubMed Web of Science ®Google Scholar
• Calame, K. Personal communication.
   Google Scholar
• Chen, X., L. J. Ko, L. Jayaraman, and J. Prives 1996. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10:2438–2451.
   PubMed Web of Science ®Google Scholar
• Chesebro, B., K. Wehrly, M. Cloyd, W. Britt, J. Portis, J. Collins, and J. Nishio 1981. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: Friend-specific and FMR-specific antigens. Virology 112:131–144.
   PubMedGoogle Scholar
• Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and J. Leder 1995. Mice lacking p21Cip1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675–684.
   PubMed Web of Science ®Google Scholar
• de Stanchina, E., M. E. McCurrach, F. Zindy, S.-Y. Shieh, G. Ferbeyre, A. V. Samuelson, C. Prives, M. F. Roussel, C. J. Sherr, and J. Lowe 1998. E1A signaling to p53 involves the p19ARF tumor suppressor. Genes Dev. 12:2434–2442.
   PubMed Web of Science ®Google Scholar
• Dulic, V., W. K. Kaufmann, S. J. Wilson, T. D. Tisty, E. Lees, J. W. Harper, S. J. Elledge, and J. Reed 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013–1023.
   PubMed Web of Science ®Google Scholar
• El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and J. Vogelstein 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825.
   PubMed Web of Science ®Google Scholar
• Engelman, A., and J. Rosenberg 1990. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity. J. Virol. 64:4242–4251.
   PubMedGoogle Scholar
• Friedlander, P., Y. Haupt, C. Prives, and J. Oren 1996. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol. 16:4961–4971.
   PubMed Web of Science ®Google Scholar
• Green, P. L., D. A. Kaehler, L. M. Bennett, and J. Risser 1989. Multiple steps are required for the induction of tumors by Abelson murine leukemia virus. J. Virol. 63:1989–1994.
   PubMedGoogle Scholar
• Green, P. L., D. A. Kaehler, and J. Risser 1987. Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis. J. Virol. 61:2192–2197.
   PubMedGoogle Scholar
• Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and J. Elledge 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1-cyclin-dependent kinases. Cell 75:805–816.
   PubMed Web of Science ®Google Scholar
• Jenab, J., and N. Rosenberg. Unpublished data.
   Google Scholar
• Jones, J. M., L. Attardi, L. A. Godley, R. Laucirica, D. Medina, T. Jacks, H. E. Varmus, and J. Donehower 1997. Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis. Cell Growth Differ. 8:829–838.
   PubMedGoogle Scholar
• Kamijo, T., F. Zindy, M. F. Roussel, D. E. Quelle, J. R. Downing, R. A. Ashmun, G. Grosveld, and J. Sherr 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649–659.
   PubMed Web of Science ®Google Scholar
• Kobayashi, T., U. Consoli, M. Audreeff, H. Shiku, A. B. Deisseroth, and J. Zhang 1995. Activation of p21WAF1/CIP1 expression in a temperature-sensitive mutant of human p53 does not lead to apoptosis. Oncogene 11:2311–2316.
   PubMed Web of Science ®Google Scholar
• Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323–331.
   PubMed Web of Science ®Google Scholar
• McGahon, A. J., W. K. Nishioka, S. J. Martin, A. Mahboubi, T. G. Cotter, and J. Green 1995. Regulation of Fas apoptotic cell death by Abl. J. Biol. Chem. 270:22625–22631.
   PubMed Web of Science ®Google Scholar
• Miyashita, T., and J. Reed 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293–299.
   PubMed Web of Science ®Google Scholar
• Mock, B. A., E. S. Ramsey, and J. Mock 1998. Cdkn2, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr. Proc. Natl. Acad. Sci. USA 95:2429–2434.
   PubMedGoogle Scholar
• Parmar, K., R. C. Huebner, and J. Rosenberg 1991. Carboxyl-terminal determinants of Abelson protein important for lymphoma induction. J. Virol. 65:6478–6485.
   PubMedGoogle Scholar
• Parmar, K., and J. Rosenberg 1996. Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation. J. Virol. 70:1009–1015.
   PubMedGoogle Scholar
• Pomerantz, J., N. Schreiber-Agus, N. J. Liegeois, A. Silverman, L. Alland, L. Chin, J. Potes, K. Chen, I. Orlow, H. W. Lee, C. Cordon-Cardo, and J. DePinho 1998. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53. Cell 92:713–723.
   PubMed Web of Science ®Google Scholar
• Prives, C. 1998. Signaling to p53: breaking the MDM2-p53 circuit. Cell 95:5–8.
   PubMed Web of Science ®Google Scholar
• Prokocimer, M., and J. Rotter 1994. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood 84:2391–2411.
   PubMed Web of Science ®Google Scholar
• Quelle, D. E., F. Zindy, R. A. Ashmun, and J. Sherr 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993–1000.
   PubMed Web of Science ®Google Scholar
• Radfar, A., I. Unnikrishnan, H.-W. Lee, R. A. DePinho, and J. Rosenberg 1998. P19Arf induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation. Proc. Natl. Acad. Sci. USA 95:13194–13199.
   PubMed Web of Science ®Google Scholar
• Reid, S., R. Cross, and J. Snow 1996. Combined Hoechst 33342 and merocyanin 540 staining to examine murine B cell cycle stage, viability and apoptosis. J Immunol. Methods 192:43–54.
   PubMedGoogle Scholar
• Risser, R., D. Kaehler, and J. Lamph 1985. Different genes control the susceptibility of mice to Moloney or Abelson murine leukemia viruses. J. Virol. 55:547–553.
   PubMedGoogle Scholar
• Risser, R., M. Potter, and J. Rowe 1978. Abelson virus-induced lymphomagenesis in mice. J. Exp. Med. 148:714–726.
   PubMed Web of Science ®Google Scholar
• Rosenberg, N. 1991. abl oncogenes. Semin. Virol. 2:365–374.
   Google Scholar
• Rosenberg, N., and J. Baltimore 1976. A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J. Exp. Med. 143:1453–1463.
   PubMed Web of Science ®Google Scholar
• Ryan, K., and J. Vousden 1998. Characterization of structural p53 mutants which show selective defects in apoptosis but no cell cycle arrest. Mol. Cell. Biol. 18:3692–3698.
   PubMed Web of Science ®Google Scholar
• Sabbatini, P., S.-K. Chiou, L. Rao, and J. White 1995. Modulation of p53-mediated transcriptional repression and apoptosis by adenovirus E1B 19K protein. Mol. Cell. Biol. 15:1060–1070.
   PubMedGoogle Scholar
• Sawyers, C. L., W. Callahan, and J. Witte 1992. Dominant negative myc blocks transformation by abl oncogenes. Cell 70:901–910.
   PubMed Web of Science ®Google Scholar
• Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and J. Lowe 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593–602.
   PubMed Web of Science ®Google Scholar
• Shen, Y. Q., and J. Shenk 1994. Relief of p53-mediated transcriptional repression by the adenovirus E1B 19K protein or the cellular bcl-2 protein. Proc. Natl. Acad. Sci. USA 91:8940–8944.
   PubMedGoogle Scholar
• Sherr, C. J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984–2991.
   PubMed Web of Science ®Google Scholar
• Shick, L., J. H. Carman, K. Somasundaram, M. Burrell, D. E. Hill, Y.-X. Zeng, Y. Wang, K. G. Wiman, K. Salhany, T. R. Kadesch, J. G. Monroe, L. A. Donehower, and J. El-Deiry 1997. Decreased immunoglobulin deposition in tumors and increased immature B cells in p53-null mice. Cell Growth Differ. 8:121–131.
   PubMedGoogle Scholar
• Skorski, T., M. Nieborowska-Skorska, P. Wlodarski, P. Perrotti, R. Martinez, M. A. Wasik, and J. Calabretta 1996. Blastic transformation of p53-deficient bone marrow cells by P210 bcr/abl tyrosine kinase. Proc. Natl. Acad. Sci. USA 93:13137–13142.
   PubMed Web of Science ®Google Scholar
• Stein, D. H., and J. Dulic 1995. Origins of G1 arrest in senescent human diploid fibroblasts. Bioessays 17:537–543.
   PubMedGoogle Scholar
• Stott, F. J., S. Bates, M. C. James, B. B. McConnell, M. Starborg, S. Brookes, I. Palmero, K. Ryan, E. Hara, K. H. Vousden, and J. Peters 1998. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:5001–5014.
   PubMed Web of Science ®Google Scholar
• Stuppia, L., G. Calabrese, R. Peila, P. Guanciali-Franchi, E. Morizio, A. Spadano, and J. Palka 1997. p53 loss and point mutations are associated with suppression of apoptosis and progression of CML into myeloid blastic crisis. Cancer Genet. Cytogenet. 98:28–35.
   PubMed Web of Science ®Google Scholar
• Thome, K. C., A. Radfar, and J. Rosenberg 1997. Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells. J. Virol. 71:8149–8156.
   PubMed Web of Science ®Google Scholar
• Votja, P. J., and J. Barrett 1995. Genetic analysis of cellular senescence. Biochim. Biophys. Acta 1242:29–41.
   PubMedGoogle Scholar
• Wagner, A., J. M. Kokontis, and J. Hay 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 8:2817–2830.
   PubMed Web of Science ®Google Scholar
• Wang, J. Y. J. 1993. Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr. Opin. Genet. Dev. 3:35–43.
   PubMedGoogle Scholar
• Whitlock, C. A., and J. Witte 1981. Abelson virus-infected cells exhibit restricted in vitro growth and low oncogenic potential. J. Virol. 40:577–584.
   PubMedGoogle Scholar
• Whitlock, C. A., S. F. Ziegler, and J. Witte 1983. Progression of the transformed phenotype in clonal lines of Abelson virus-infected lymphocytes. Mol. Cell. Biol. 3:596–604.
   PubMedGoogle Scholar
• Wolf, D., and J. Rotter 1984. Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences. Mol. Cell. Biol. 4:1402–1410.
   PubMed Web of Science ®Google Scholar
• Wong, K. K., X. Zou, K. T. Merrell, A. J. Patel, K. B. Marcu, S. Chellappan, and J. Calame 1995. v-Abl activates c-myc transcription through the E2F site. Mol. Cell. Biol. 15:6535–6544.
   PubMedGoogle Scholar
• Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and J. Beach 1993. p21 is a universal inhibitor of cyclin kinases. Nature (London) 366:707–710.
   PubMedGoogle Scholar
• Zindy, F., C. M. Eischen, D. H. Randle, T. Kamijo, J. L. Cleveland, C. J. Sherr, and J. Roussel 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424–2433.
   PubMed Web of Science ®Google Scholar
• Zou, X., S. Rudchenko, K.-K. Wong, and J. Calame 1997. Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases. Genes Dev. 11:654–662.
   PubMedGoogle Scholar